# A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis

> **NCT03688555** · PHASE2 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Bilateral Nasal Polyposis

## Interventions

- **DRUG:** ACT-774312
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03688555
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-19
- **Primary completion:** 2020-11-24
- **Final completion:** 2020-12-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688555, "A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03688555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*